The degradation of glucagon-like peptide-1 involves both dipeptidyl peptidase IV and neutral endopeptidase 24.11 in vivo

被引：0
|
作者：
Plamboeck, A
Holst, JJ
Carr, RD
Deacon, CF
机构：
[1] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
来源：
REGULATORY PEPTIDES | 2004年 / 122卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A5
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like peptide-1 in vivo
    Plamboeck, A
    Holst, JJ
    Carr, RD
    Deacon, CF
    [J]. DIPEPTIDYL AMINOPEPTIDASES IN HEALTH AND DISEASE, 2003, 524 : 303 - 312
  • [2] Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig
    A. Plamboeck
    J. J. Holst
    R. D. Carr
    C. F. Deacon
    [J]. Diabetologia, 2005, 48 : 1882 - 1890
  • [3] Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig
    Plamboeck, A
    Holst, JJ
    Carr, RD
    Deacon, CF
    [J]. DIABETOLOGIA, 2005, 48 (09) : 1882 - 1890
  • [4] Augmentation of glucagon-like peptide-1 mediated insulin release by dual neutral endopeptidase 24.11 and dipeptidyl peptidase IV inhibition in pigs
    Plamboeck, A
    Holst, JJ
    Carr, RD
    Deacon, CF
    [J]. DIABETES, 2002, 51 : A343 - A343
  • [5] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1: In vitro and in vivo studies
    Deacon, CF
    Knudsen, LB
    Johansen, NL
    Madsen, K
    Holst, JJ
    [J]. DIABETOLOGIA, 1997, 40 : 492 - 492
  • [6] A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
    Lambeir, AM
    Proost, P
    Scharpé, S
    De Meester, I
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1753 - 1756
  • [7] Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide-1
    Deacon, CF
    Hughes, TE
    Holst, JJ
    [J]. DIABETES, 1998, 47 : A69 - A69
  • [8] Synthesis and Bioactivity Evaluation of Dipeptidyl Peptidase IV Resistant Glucagon-like Peptide-1 Analogues
    Zhou, Jinpei
    Ni, Shuaijian
    Zhang, Huibin
    Qian, Hai
    Chi, Yushi
    Huang, Wenlong
    Yu, Lu
    Hu, Xiaowen
    Chen, Wei
    [J]. PROTEIN AND PEPTIDE LETTERS, 2010, 17 (10): : 1290 - 1295
  • [9] Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase
    Malm-Erjefalt, Monika
    Bjornsdottir, Inga
    Vanggaard, Jan
    Helleberg, Hans
    Larsen, Uffe
    Oosterhuis, Berend
    van Lier, Jan Jaap
    Zdravkovic, Milan
    Olsen, Anette K.
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 1944 - 1953
  • [10] Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?
    Martin C. Michel
    Eric Fliers
    Cornelis J. F. Van Noorden
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377 : 205 - 207
12345